[go: up one dir, main page]

HRP20051019A2 - A method for the preparation of enantiomerically pure mirtazapine - Google Patents

A method for the preparation of enantiomerically pure mirtazapine

Info

Publication number
HRP20051019A2
HRP20051019A2 HR20051019A HRP20051019A HRP20051019A2 HR P20051019 A2 HRP20051019 A2 HR P20051019A2 HR 20051019 A HR20051019 A HR 20051019A HR P20051019 A HRP20051019 A HR P20051019A HR P20051019 A2 HRP20051019 A2 HR P20051019A2
Authority
HR
Croatia
Prior art keywords
preparation
enantiomerically pure
mirtazapine
acid
pure mirtazapine
Prior art date
Application number
HR20051019A
Other languages
English (en)
Croatian (hr)
Inventor
Hubertus Wieringa Johannes
Antonius Martinus Van De Ven Adrianus
Johannes Kemperman Gerardus
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of HRP20051019A2 publication Critical patent/HRP20051019A2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HR20051019A 2003-07-10 2004-07-05 A method for the preparation of enantiomerically pure mirtazapine HRP20051019A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03102095 2003-07-10
PCT/EP2004/051357 WO2005005410A1 (en) 2003-07-10 2004-07-05 A method for the preparation of enantiomerically pure mirtazapine

Publications (1)

Publication Number Publication Date
HRP20051019A2 true HRP20051019A2 (en) 2006-02-28

Family

ID=34042934

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20051019A HRP20051019A2 (en) 2003-07-10 2004-07-05 A method for the preparation of enantiomerically pure mirtazapine

Country Status (35)

Country Link
US (2) US8058436B2 (is)
EP (1) EP1656365B1 (is)
JP (1) JP4668184B2 (is)
KR (1) KR20060056315A (is)
CN (1) CN100558722C (is)
AR (1) AR046494A1 (is)
AT (1) ATE433965T1 (is)
AU (1) AU2004255874B2 (is)
BR (1) BRPI0412447A (is)
CA (1) CA2531165C (is)
CO (1) CO5640123A2 (is)
CY (1) CY1109327T1 (is)
DE (1) DE602004021605D1 (is)
DK (1) DK1656365T3 (is)
EC (1) ECSP066271A (is)
ES (1) ES2327123T3 (is)
HR (1) HRP20051019A2 (is)
IL (1) IL172549A0 (is)
IS (1) IS2674B (is)
LT (1) LT5382B (is)
LV (1) LV13441B (is)
MX (1) MXPA06000325A (is)
NO (1) NO20056175L (is)
NZ (1) NZ544360A (is)
PE (1) PE20050323A1 (is)
PL (1) PL1656365T3 (is)
PT (1) PT1656365E (is)
RS (1) RS20050972A (is)
RU (1) RU2352566C2 (is)
SG (1) SG144914A1 (is)
SI (1) SI1656365T1 (is)
TW (1) TWI335915B (is)
UA (1) UA83666C2 (is)
WO (1) WO2005005410A1 (is)
ZA (1) ZA200600019B (is)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5080050B2 (ja) * 2005-09-26 2012-11-21 住友化学株式会社 光学活性なピペラジン化合物の製造方法
CN102153620A (zh) * 2005-09-26 2011-08-17 住友化学株式会社 光学活性的哌嗪化合物的制造方法
TW200808804A (en) * 2006-05-22 2008-02-16 Organon Nv Mirtazapine for the treatment of neuropathic pain
TW200815370A (en) * 2006-06-16 2008-04-01 Organon Nv Stereoselective synthesis of (S)-1-methyl-3-phenylpiperazine
WO2008099715A1 (ja) * 2007-02-09 2008-08-21 Kaneka Corporation 光学活性2-アリールピペラジン誘導体の製造法
JP5192707B2 (ja) 2007-03-22 2013-05-08 住友化学株式会社 ミルタザピンの製造方法
US7994314B2 (en) 2007-04-11 2011-08-09 N.V. Organon Method for the preparation of an enantiomerically pure benzazepine
JP5635905B2 (ja) * 2007-04-11 2014-12-03 メルク・シャープ・エンド・ドーム・ベー・フェー ミルタザピンの調製方法
KR101485418B1 (ko) * 2013-05-29 2015-01-26 주식회사 메디켐코리아 고순도 미르타자핀의 제조방법
WO2016138357A1 (en) 2015-02-27 2016-09-01 Kindred Biosciences, Inc. Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats
KR102540021B1 (ko) * 2020-12-02 2023-06-07 (주)유케이케미팜 대량 생산에 적합한 미르타자핀의 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959470A (en) * 1972-11-28 1976-05-25 Mikhail Davidovich Mashkovsky Psychotropic medicinal preparation
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
IE903557A1 (en) * 1989-10-05 1991-04-10 Sankyo Co Novel tetracyclic compounds having anti-allergic and¹anti-asthmatic activities, their preparation and use
US6303595B1 (en) 1997-11-14 2001-10-16 Akzo Nobel N.V. Use of mirtazapine for treating sleep apneas
JPH11222407A (ja) * 1997-11-14 1999-08-17 Sankyo Co Ltd 新規殺菌剤
KR20020019902A (ko) 1999-04-19 2002-03-13 추후보정 피페라진 고리 함유 화합물의 신규한 합성법 및 결정화법
US20030069417A1 (en) * 1999-04-19 2003-04-10 Claude Singer Novel synthesis and crystallization of piperazine ring-containing compounds
US6068695A (en) * 1999-07-13 2000-05-30 Bayer Corporation Process for the continuous preparation of quinacridones
AU6476300A (en) 1999-09-30 2001-05-10 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a piperazine derivative
AU6474200A (en) * 1999-12-13 2001-06-18 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound
EP1658850A1 (en) 2000-02-11 2006-05-24 Akzo Nobel N.V. The use of mirtazapine for the treatment of sleep disorders
JP2001342188A (ja) * 2000-03-27 2001-12-11 Takeda Chem Ind Ltd 縮合ピラゾール誘導体、その製造法および用途
TW200538100A (en) * 2004-04-21 2005-12-01 Akzo Nobel Nv Mirtazapine salts

Also Published As

Publication number Publication date
SG144914A1 (en) 2008-08-28
TWI335915B (en) 2011-01-11
JP4668184B2 (ja) 2011-04-13
AR046494A1 (es) 2005-12-14
CY1109327T1 (el) 2014-07-02
CN100558722C (zh) 2009-11-11
LV13441B (en) 2006-08-20
KR20060056315A (ko) 2006-05-24
PE20050323A1 (es) 2005-05-16
RU2006103992A (ru) 2006-06-27
LT5382B (lt) 2006-11-27
ECSP066271A (es) 2006-07-28
DK1656365T3 (da) 2009-09-14
PL1656365T3 (pl) 2009-10-30
RS20050972A (sr) 2008-06-05
HK1086841A1 (en) 2006-09-29
IS8184A (is) 2005-12-15
TW200510426A (en) 2005-03-16
LT2005107A (en) 2006-06-27
AU2004255874B2 (en) 2010-10-28
DE602004021605D1 (de) 2009-07-30
AU2004255874A1 (en) 2005-01-20
MXPA06000325A (es) 2006-03-30
IL172549A0 (en) 2006-04-10
UA83666C2 (ru) 2008-08-11
PT1656365E (pt) 2009-09-01
IS2674B (is) 2010-09-15
NO20056175L (no) 2006-01-23
US20100179319A1 (en) 2010-07-15
EP1656365A1 (en) 2006-05-17
NZ544360A (en) 2008-05-30
BRPI0412447A (pt) 2006-09-19
ES2327123T3 (es) 2009-10-26
RU2352566C2 (ru) 2009-04-20
SI1656365T1 (sl) 2009-10-31
CA2531165C (en) 2011-08-30
CA2531165A1 (en) 2005-01-20
CO5640123A2 (es) 2006-05-31
CN1820000A (zh) 2006-08-16
US8058436B2 (en) 2011-11-15
JP2009513537A (ja) 2009-04-02
EP1656365B1 (en) 2009-06-17
US20060229300A1 (en) 2006-10-12
ATE433965T1 (de) 2009-07-15
ZA200600019B (en) 2007-01-31
WO2005005410A1 (en) 2005-01-20

Similar Documents

Publication Publication Date Title
CY1109327T1 (el) Μια μεθοδος για την παρασκευη εναντιομερικα καθαρης μιρταζαπινης
ECSP055883A (es) Nuevos derivados de piridazin-3(2h)-ona
ATE417051T1 (de) Polymorphe von clopidogrel-hydrogensulfat
ATE361345T1 (de) Metalloxyphthalocyaninverbindungen
ATE338461T1 (de) Pyrazolpyrimidinfungizide
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
MY144633A (en) New tricyclic derivatives, method of preparing same and pharmaceutical compositions containing them
CR9472A (es) Derivados de aminoacidos
ATE410485T1 (de) Härtbare farbige zusammensetzung, farbfilter und verfahren zu deren herstellung
ATE527258T1 (de) Pyrroloä2,3-cüpyridinverbindung, verfahren zu deren herstellung und anwendung
EA200600601A1 (ru) Производные аминопиридина в качестве ингибиторов индуцируемой no-синтазы
ATE415404T1 (de) Lösungsmittelfreies verfahren zur herstellung von diketopyrrolopyrrol-derivaten
DE502007006121D1 (de) Elektrochemische herstellung sterisch gehinderter amine
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
ATE526312T1 (de) Verfahren zur herstellung von reinen 4- pyrrolidinophenylbenzyletherderivaten als maob- inhibitoren
NO20061344L (no) Imidazopyridinderivater som induserbare NO-syntaseoinhibitorer
PT1317455E (pt) Processo para a preparacao de um composto de imidazopiridina substituido
UY29012A1 (es) "oxazolididonas y composiciones y metodos relacionados"
ATE444323T1 (de) Neuartige epoxidverbindungen und verfahren zu ihrer herstellung
ATE423096T1 (de) Verfahren zur herstellung von 2- azabicycloä3.3.0üoctan-3-carbonsäurederivaten
ECSP056103A (es) Tratamiento de pigmentos de alto rendimiento
ATE466003T1 (de) Herstellung von 2-aminothiazol-5- carbonsäurederivaten
NO20061343L (no) Imidazo[4,5-b]pyridinderivater som induserbare NO-syntaseinhibitorer
DE50304869D1 (de) Verfahren zur herstellung einer spezifischen kristallmodifikation von 2-(2-chlor-4-mesyl-benzoyl)-cyclohexan-1,3-dion
HRP20060168A2 (en) Novel method of preparing 3-fluorinated quinolines

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PPPP Transfer of rights

Owner name: N.V. ORGANON, NL

ODRP Renewal fee for the maintenance of a patent

Payment date: 20110629

Year of fee payment: 8

OBST Application withdrawn